Annual CAPEX
$730.00 K
+$143.00 K+24.36%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual capital expenditures is $730.00 thousand, with the most recent change of +$143.00 thousand (+24.36%) on December 31, 2023.
- During the last 3 years, LVTX annual CAPEX has risen by +$228.00 thousand (+45.42%).
- LVTX annual CAPEX is now -4.45% below its all-time high of $764.00 thousand, reached on December 31, 2021.
Performance
LVTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- LVTX quarterly capital expenditures is not available.
Performance
LVTX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- LVTX TTM capital expenditures is not available.
Performance
LVTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
LVTX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.4% | - | - |
| 3 y3 years | +45.4% | - | - |
| 5 y5 years | - | - | - |
LVTX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.5% | +24.4% | ||||
| 5 y | 5-year | -4.5% | +45.4% | ||||
| alltime | all time | -4.5% | +45.4% |
LAVA Therapeutics NV CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $730.00 K(+24.4%) | $0.00(-100.0%) | $730.00 K(-26.6%) |
| Sep 2023 | - | $6000.00(-97.3%) | $995.00 K(+3.2%) |
| Jun 2023 | - | $224.00 K(-55.2%) | $964.00 K(+26.2%) |
| Mar 2023 | - | $500.00 K(+88.7%) | $764.00 K(+30.2%) |
| Dec 2022 | $587.00 K | $265.00 K(-1160.0%) | $587.00 K(+19.8%) |
| Sep 2022 | - | -$25.00 K(-204.2%) | $490.00 K(-47.7%) |
| Jun 2022 | - | $24.00 K(-92.6%) | $937.00 K(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $323.00 K(+92.3%) | $921.00 K(+20.5%) |
| Dec 2021 | $764.00 K(+52.2%) | $168.00 K(-60.2%) | $764.00 K(+16.8%) |
| Sep 2021 | - | $422.00 K(+5175.0%) | $654.20 K(+27.0%) |
| Jun 2021 | - | $8000.00(-95.2%) | $515.20 K(-3.6%) |
| Mar 2021 | - | $166.00 K(+185.2%) | $534.60 K(+45.0%) |
| Dec 2020 | $502.00 K | $58.20 K(-79.4%) | $368.60 K(+18.8%) |
| Sep 2020 | - | $283.00 K(+932.8%) | $310.40 K(+1032.8%) |
| Jun 2020 | - | $27.40 K | $27.40 K |
FAQ
- What is LAVA Therapeutics NV annual capital expenditures?
- What is the all time high annual CAPEX for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for LAVA Therapeutics NV?
- What is the all time high TTM CAPEX for LAVA Therapeutics NV?
What is LAVA Therapeutics NV annual capital expenditures?
The current annual CAPEX of LVTX is $730.00 K
What is the all time high annual CAPEX for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual capital expenditures is $764.00 K
What is LAVA Therapeutics NV annual CAPEX year-on-year change?
Over the past year, LVTX annual capital expenditures has changed by +$143.00 K (+24.36%)
What is the all time high quarterly CAPEX for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly capital expenditures is $500.00 K
What is the all time high TTM CAPEX for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high TTM capital expenditures is $995.00 K